TrialJournal of cancer research and clinical oncology2024

Two doses of fosaprepitant included prophylactic treatment for the three-day cisplatin-based chemotherapy induced nausea and vomiting.

Yanying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.